Wolverine Trading
AERI

Wolverine Trading’s Aerie Pharmaceuticals AERI Stock Holding History

Wolverine Trading’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-11,600
Closed -$107K – 6157
2022
Q1 		$107K Buy
+11,600
New +$89.4K ﹤0.01% 4797
2020
Q3 		– Sell
-11,700
Closed -$174K – 5380
2020
Q2 		$174K Sell
11,700
-6,600
-36% -$97.6K ﹤0.01% 3910
2020
Q1 		$247K Buy
18,300
+5,100
+39% +$96.8K ﹤0.01% 3441
2019
Q4 		$306K Sell
13,200
-22,100
-63% -$458K ﹤0.01% 3574
2019
Q3 		$718K Buy
35,300
+7,900
+29% +$181K ﹤0.01% 2257
2019
Q2 		$810K Buy
27,400
+12,000
+78% +$462K ﹤0.01% 2236
2019
Q1 		$732K Buy
15,400
+9,600
+166% +$423K ﹤0.01% 2369
2018
Q4 		$206K Sell
5,800
-200
-3% -$9.38K ﹤0.01% 3669
2018
Q3 		$369K Buy
+6,000
New +$386K ﹤0.01% 3482

Other funds holding AERI

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Wolverine Trading's AERI Position: Q1 2020 in Review

Wolverine Trading sold out of Aerie Pharmaceuticals (AERI) in Q1 2020, closing a stake of 8,637 shares — an estimated $164K sold.

Wolverine Trading first reported a position in AERI in Q3 2018 and held it in 5 quarters. The position peaked at $791K in Q1 2019. 155 funds tracked by Wall St. Rank hold AERI as of Q1 2020.

  • Wolverine Trading reported no remaining Aerie Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Wolverine Trading sold 8,637 Aerie Pharmaceuticals shares in Q1 2020, an estimated $164K.
  • Wolverine Trading first reported a position in Aerie Pharmaceuticals in Q3 2018 and held it in 5 quarters.
  • Wolverine Trading's Aerie Pharmaceuticals position peaked at $791K in Q1 2019.
  • 155 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q1 2020.

Based on Wolverine Trading's 13F filing for Q1 2020, filed 11 May 2020.